Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Dependance of Stiffening on Depth in Riboflavin/UVA treated Corneas
Schilde, T., Spörl, E., Kohlhaas, M., Pillunat, L. E.
Dept. of Ophthalmology, University Hospital Carl Gustav Carus, Dresden
Purpose: Treatment of keratoconus with riboflavin/UVA is based on a significant stiffening of the cornea. The study should show until which depth the stiffening effect could be proved biomechanically.
Method: From 20 enucleated porcine eyes, 10 eyes were treated with riboflavin as photosensitizer and UVA (370 nm, 3 mW/cm2, 30 min) and 10 eyes served as controls. Two flaps of 200 mm thickness were cut with a microkeratom from each eye and strips of 5 mm width and 7 mm length were prepared. Stress-strain curves were measured with a material tester to characterize the stiffening effect.
Results: The stiffening of the first treated flaps was increased (P = 0.003) in comparison to the second treated flaps and the control flaps. Stress at 5 % strain achieved 251±160,7x103 N/m2 for the first treated flaps in comparison to 111±64,2x103 N/m2 for the first control flaps. The second treated flaps (119±68,1x103 N/m2) are 20 % stiffer than the second control flaps (99±50,1x103 N/m2) but the difference is not significant (P = 0.5). The stress of the second control flaps is smaller as the first one but the difference does not reach significance (P = 0.36).
Conclusions: Treatment of the cornea with riboflavin/UVA leads to a significant stiffening in th